From January to June this year, a total of 54 companies achieved new results in the clinical application of domestic cell therapy, involving 57 cell therapy drugs.

iPSC is regarded as a revolutionary scientific discovery, which brings new hopes and opportunities for medical research and clinical application.

According to CCTV News, there are more than 400 cell and gene therapy products in clinical trials in China. Among them, there are only 100 stem cell products.

For RA, it may be possible to induce inflammatory relief through permanent immune tolerance, so as to prevent the continuous deterioration of joint structure and repair existing injuries.

The rapid emergence of stem cell technology provides a new solution for the treatment of bone diseases.

Cell products are expected to join the ranks of advanced therapeutic drugs.

Stem cells have proved to be particularly aesthetically attractive.

FDA is no longer required to report two common but sometimes serious side effects of a small number of CAR-T treatments in order to "minimize the burden on the health care system".